News
Holli Kolkey VP of Corporate Communications (650) 922-1269 [email protected] Taiho Pharmaceutical Co., Ltd. Inquiries: Yuji Kawahara Strategic Communications +81-3-3293-2878 [email protected] ...
Taiho Oncology, Inc., and Taiho Pharmaceutical Co., Ltd., announced today that the U.S. Food and Drug Administration (FDA) has accepted their supplemental new drug application (sNDA) for INQOVI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback